Hints for control of infection in unique extrahepatic vertebral alveolar echinococcosis

The prognosis of vertebral alveolar echinococcosis (AE) is poor. We report on the unique outcome of a patient with preexisting liver cirrhosis, in whom a diagnosis of vertebral AE was established on vertebral histopathology (D4 corporectomy in 2010 for paraplegia). Therapeutic drug monitoring of alb...

Full description

Saved in:
Bibliographic Details
Published inInfection Vol. 45; no. 3; pp. 365 - 368
Main Authors Faucher, Jean-François, Descotes-Genon, Cécile, Hoen, Bruno, Godard, Joël, Félix, Sophie, Aubry, Sébastien, Blagosklonov, Oleg, Grenouillet, Frédéric, Brientini, Marie-Pascale, Richou, Carine, Bresson-Hadni, Solange, Chirouze, Catherine
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.06.2017
Springer Nature B.V
Springer Verlag
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The prognosis of vertebral alveolar echinococcosis (AE) is poor. We report on the unique outcome of a patient with preexisting liver cirrhosis, in whom a diagnosis of vertebral AE was established on vertebral histopathology (D4 corporectomy in 2010 for paraplegia). Therapeutic drug monitoring of albendazole (ABZ) showed that a low dosage was appropriate. The patient recovered and ABZ withdrawal was decided in 2014, with no relapse 18 months later. In this patient, infection was purely or mainly localized in the dorsal spine, and this may have been favored by liver cirrhosis. A longer follow-up is, however, needed to confirm cure.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0300-8126
1439-0973
DOI:10.1007/s15010-016-0974-z